Dept of Cardiology, M S Ramaiah Medical College, Bangalore, India.
Indian Heart J. 2020 May-Jun;72(3):160-165. doi: 10.1016/j.ihj.2020.05.011. Epub 2020 May 29.
Long term right ventricular pacing can have deleterious effects on left ventricular (LV) function. His bundle pacing (HBP), a novel procedure can probably circumvent this setback. We investigated if (1) HBP is associated with pacing induced LV dysfunction by using LV global longitudinal strain (GLS) and (2) intermediate term performance of the Select Secure (3830) lead in the His bundle location. This report is probably the first on HBP in the Indian population.
61 patients, with normal LV ejection fraction (EF) with a guideline based indication for permanent pacing underwent a HBP pacemaker implantation using the His Select Secure 3830 lead; with lead guided mapping for locating the His bundle. The patients underwent GLS assessment; evaluation of the His lead parameters - sensing, impedance and capture thresholds immediately after implantation and at 6 months in addition to the standard follow up.
At 6 month follow up, the average GLS did not show significant variation from baseline in patients requiring ventricular pacing more than 40% and was similar, irrespective of selective or non selective His bundle pacing. All the patients had stable pacemaker parameters - with little change in capture threshold, lead impedance or sensing of the His bundle lead - implying electrical and mechanical stability on intermediate term follow-up.
HBP is a feasible procedure in the hands of an experienced operator, with stable lead performance. It does not appear to be associated with pacing mediated left ventricular dysfunction at intermediate term follow up. It should probably become the default method of permanent pacing.
长期右心室起搏可能对左心室(LV)功能产生有害影响。希氏束起搏(HBP)是一种新的方法,可能可以避免这种问题。我们研究了(1)HBP 是否会通过左心室整体纵向应变(GLS)引起起搏诱导的 LV 功能障碍,以及(2)在希氏束位置的 SelectSecure(3830)导联的中期性能。这可能是印度人群中首例关于 HBP 的报告。
61 名患者,LV 射血分数(EF)正常,根据指南有永久性起搏的适应证,使用 His SelectSecure 3830 导联进行 HBP 起搏器植入;通过引导导联映射定位希氏束。患者接受 GLS 评估;在植入后即刻和 6 个月时评估希氏束导联的参数 - 感知、阻抗和捕获阈值,以及标准随访。
在 6 个月的随访中,需要心室起搏超过 40%的患者的平均 GLS 与基线相比没有显著变化,并且无论是否选择希氏束起搏,情况都是相似的。所有患者的起搏器参数都稳定 - 希氏束导联的捕获阈值、导联阻抗或感知变化很小 - 这意味着在中期随访中具有电和机械稳定性。
HBP 是一种在有经验的操作者手中可行的方法,具有稳定的导联性能。在中期随访中,它似乎与起搏介导的左心室功能障碍无关。它可能应该成为永久性起搏的默认方法。